New Scientist on MSN
'Weaponised' CAR T-cell therapy shows promise against solid tumours
So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...
Medpage Today on MSN
Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer
Among 16 patients with this difficult-to-treat tumor "with few treatment options," the confirmed overall response rate (ORR) ...
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main ...
AZoLifeSciences on MSN
Cracking the Code of T Cell Expansion Inside Tumors ...
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key to the ...
The oncology pipeline is marked by heterogeneity and complexity (1). Moving forward, pharmaceutical scientists must navigate the intersection of advanced biology, next-generation delivery platforms, ...
SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 22, 2025 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a ...
Nektar Therapeutics (Nasdaq: NKTR) announced today that new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin ...
Rates of invasive lobular carcinoma are increasing in the US more than three times faster than those of all other breast cancers. A doctor explains how to lower your risk.
The Chosun Ilbo on MSN
Prostate Cancer Treatment Enhanced by Targeting Protective Proteins
Chinese and Australian scientists have discovered a treatment that weakens prostate cancer cells, the South China Morning ...
Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...
The FDA has granted orphan drug status to the experimental T-cell, or Treg, therapy CK0803, being developed by Cellenkos to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback